Correlation Between Arctic Blue and Vicore Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arctic Blue and Vicore Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arctic Blue and Vicore Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arctic Blue Beverages and Vicore Pharma Holding, you can compare the effects of market volatilities on Arctic Blue and Vicore Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arctic Blue with a short position of Vicore Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arctic Blue and Vicore Pharma.

Diversification Opportunities for Arctic Blue and Vicore Pharma

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Arctic and Vicore is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Arctic Blue Beverages and Vicore Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vicore Pharma Holding and Arctic Blue is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arctic Blue Beverages are associated (or correlated) with Vicore Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vicore Pharma Holding has no effect on the direction of Arctic Blue i.e., Arctic Blue and Vicore Pharma go up and down completely randomly.

Pair Corralation between Arctic Blue and Vicore Pharma

Assuming the 90 days trading horizon Arctic Blue Beverages is expected to under-perform the Vicore Pharma. In addition to that, Arctic Blue is 1.66 times more volatile than Vicore Pharma Holding. It trades about -0.03 of its total potential returns per unit of risk. Vicore Pharma Holding is currently generating about -0.02 per unit of volatility. If you would invest  1,778  in Vicore Pharma Holding on September 12, 2024 and sell it today you would lose (1,006) from holding Vicore Pharma Holding or give up 56.58% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Arctic Blue Beverages  vs.  Vicore Pharma Holding

 Performance 
       Timeline  
Arctic Blue Beverages 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arctic Blue Beverages has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Vicore Pharma Holding 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Vicore Pharma Holding are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Vicore Pharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Arctic Blue and Vicore Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arctic Blue and Vicore Pharma

The main advantage of trading using opposite Arctic Blue and Vicore Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arctic Blue position performs unexpectedly, Vicore Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicore Pharma will offset losses from the drop in Vicore Pharma's long position.
The idea behind Arctic Blue Beverages and Vicore Pharma Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets